메뉴 건너뛰기




Volumn 40, Issue 5, 2011, Pages 371-388

Treatment of Early Rheumatoid Arthritis: Concepts in Management

Author keywords

Biologic agents; Disease modifying antirheumatic drugs; Early rheumatoid arthritis; Poor prognosis; Review

Indexed keywords

ABATACEPT; ADALIMUMAB; BETAMETHASONE; CELECOXIB; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; CYCLOSPORIN; DISEASE MODIFYING ANTIRHEUMATIC DRUG; ETANERCEPT; HYDROXYCHLOROQUINE; INFLIXIMAB; METHOTREXATE; PLACEBO; PREDNISOLONE; PREDNISONE; RHEUMATOID FACTOR; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID; TRIAMCINOLONE ACETONIDE;

EID: 79953041295     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semarthrit.2010.10.004     Document Type: Article
Times cited : (34)

References (57)
  • 1
    • 0034767757 scopus 로고    scopus 로고
    • Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis
    • Boers M., Kostense P.J., Verhoeven A.C., van der Linden S. Inflammation and damage in an individual joint predict further damage in that joint in patients with early rheumatoid arthritis. Arthritis Rheum 2001, 44:2242-2246.
    • (2001) Arthritis Rheum , vol.44 , pp. 2242-2246
    • Boers, M.1    Kostense, P.J.2    Verhoeven, A.C.3    van der Linden, S.4
  • 2
    • 0036083566 scopus 로고    scopus 로고
    • The pathogenesis of rheumatoid arthritis: a guide to therapy
    • Jenkins J.K., Hardy K.J., McMurray R.W. The pathogenesis of rheumatoid arthritis: a guide to therapy. Am J Med Sci 2002, 323:171-180.
    • (2002) Am J Med Sci , vol.323 , pp. 171-180
    • Jenkins, J.K.1    Hardy, K.J.2    McMurray, R.W.3
  • 3
    • 35948933049 scopus 로고    scopus 로고
    • Early rheumatoid arthritis-is there a window of opportunity?
    • Cush J.J. Early rheumatoid arthritis-is there a window of opportunity?. J Rheumatol Suppl 2007, 80:1-7.
    • (2007) J Rheumatol Suppl , vol.80 , pp. 1-7
    • Cush, J.J.1
  • 4
    • 0030451380 scopus 로고    scopus 로고
    • Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ
    • Mulherin D., Fitzgerald O., Bresnihan B. Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ. Br J Rheumatol 1996, 35:1263-1268.
    • (1996) Br J Rheumatol , vol.35 , pp. 1263-1268
    • Mulherin, D.1    Fitzgerald, O.2    Bresnihan, B.3
  • 5
    • 33750324355 scopus 로고    scopus 로고
    • Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes
    • Landewe R., van der Heijde D., Klareskog L., van Vollenhoven R., Fatenejad S. Disconnect between inflammation and joint destruction after treatment with etanercept plus methotrexate: results from the trial of etanercept and methotrexate with radiographic and patient outcomes. Arthritis Rheum 2006, 54:3119-3125.
    • (2006) Arthritis Rheum , vol.54 , pp. 3119-3125
    • Landewe, R.1    van der Heijde, D.2    Klareskog, L.3    van Vollenhoven, R.4    Fatenejad, S.5
  • 6
    • 67549115310 scopus 로고    scopus 로고
    • Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis
    • van der Kooij S.M., le Cessie S., Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., van Zeben D., Kerstens P.J., et al. Clinical and radiological efficacy of initial vs delayed treatment with infliximab plus methotrexate in patients with early rheumatoid arthritis. Ann Rheum Dis 2009, 68:1153-1158.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1153-1158
    • van der Kooij, S.M.1    le Cessie, S.2    Goekoop-Ruiterman, Y.P.3    de Vries-Bouwstra, J.K.4    van Zeben, D.5    Kerstens, P.J.6
  • 7
    • 3242677099 scopus 로고    scopus 로고
    • Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial
    • Grigor C., Capell H., Stirling A., McMahon A.D., Lock P., Vallance R., et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 2004, 364:263-269.
    • (2004) Lancet , vol.364 , pp. 263-269
    • Grigor, C.1    Capell, H.2    Stirling, A.3    McMahon, A.D.4    Lock, P.5    Vallance, R.6
  • 8
    • 0033945112 scopus 로고    scopus 로고
    • Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis
    • Plant M.J., Williams A.L., O'Sullivan M.M., Lewis P.A., Coles E.C., Jessop J.D. Relationship between time-integrated C-reactive protein levels and radiologic progression in patients with rheumatoid arthritis. Arthritis Rheum 2000, 43:1473-1477.
    • (2000) Arthritis Rheum , vol.43 , pp. 1473-1477
    • Plant, M.J.1    Williams, A.L.2    O'Sullivan, M.M.3    Lewis, P.A.4    Coles, E.C.5    Jessop, J.D.6
  • 9
    • 0029091107 scopus 로고
    • Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification)
    • van der Heijde D.M., van Leeuwen M.A., van Riel P.L., van de Putte L.B. Radiographic progression on radiographs of hands and feet during the first 3 years of rheumatoid arthritis measured according to Sharp's method (van der Heijde modification). J Rheumatol 1995, 22:1792-1796.
    • (1995) J Rheumatol , vol.22 , pp. 1792-1796
    • van der Heijde, D.M.1    van Leeuwen, M.A.2    van Riel, P.L.3    van de Putte, L.B.4
  • 10
    • 0024368707 scopus 로고
    • Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease
    • Fuchs H.A., Kaye J.J., Callahan L.F., Nance E.P., Pincus T. Evidence of significant radiographic damage in rheumatoid arthritis within the first 2 years of disease. J Rheumatol 1989, 16:585-591.
    • (1989) J Rheumatol , vol.16 , pp. 585-591
    • Fuchs, H.A.1    Kaye, J.J.2    Callahan, L.F.3    Nance, E.P.4    Pincus, T.5
  • 11
    • 0031817901 scopus 로고    scopus 로고
    • Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset
    • McQueen F.M., Stewart N., Crabbe J., Robinson E., Yeoman S., Tan P.L., et al. Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosions at four months after symptom onset. Ann Rheum Dis 1998, 57:350-356.
    • (1998) Ann Rheum Dis , vol.57 , pp. 350-356
    • McQueen, F.M.1    Stewart, N.2    Crabbe, J.3    Robinson, E.4    Yeoman, S.5    Tan, P.L.6
  • 12
    • 3242886819 scopus 로고    scopus 로고
    • Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis
    • Nell V.P., Machold K.P., Eberl G., Stamm T.A., Uffmann M., Smolen J.S. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 2004, 43:906-914.
    • (2004) Rheumatology (Oxford) , vol.43 , pp. 906-914
    • Nell, V.P.1    Machold, K.P.2    Eberl, G.3    Stamm, T.A.4    Uffmann, M.5    Smolen, J.S.6
  • 13
    • 0035886157 scopus 로고    scopus 로고
    • Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies
    • Lard L.R., Visser H., Speyer I., vander Horst-Bruinsma I.E., Zwinderman A.H., Breedveld F.C., et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am J Med 2001, 111:446-451.
    • (2001) Am J Med , vol.111 , pp. 446-451
    • Lard, L.R.1    Visser, H.2    Speyer, I.3    vander Horst-Bruinsma, I.E.4    Zwinderman, A.H.5    Breedveld, F.C.6
  • 14
    • 0036225386 scopus 로고    scopus 로고
    • Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis
    • Mottonen T., Hannonen P., Korpela M., Nissila M., Kautiainen H., Ilonen J., et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002, 46:894-898.
    • (2002) Arthritis Rheum , vol.46 , pp. 894-898
    • Mottonen, T.1    Hannonen, P.2    Korpela, M.3    Nissila, M.4    Kautiainen, H.5    Ilonen, J.6
  • 15
    • 1342343999 scopus 로고    scopus 로고
    • Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis
    • van Aken J., Lard L.R., le Cessie S., Hazes J.M., Breedveld F.C., Huizinga T.W. Radiological outcome after four years of early versus delayed treatment strategy in patients with recent onset rheumatoid arthritis. Ann Rheum Dis 2004, 63:274-279.
    • (2004) Ann Rheum Dis , vol.63 , pp. 274-279
    • van Aken, J.1    Lard, L.R.2    le Cessie, S.3    Hazes, J.M.4    Breedveld, F.C.5    Huizinga, T.W.6
  • 16
    • 0033535754 scopus 로고    scopus 로고
    • Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group
    • Mottonen T., Hannonen P., Leirisalo-Repo M., Nissila M., Kautiainen H., Korpela M., et al. Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group. Lancet 1999, 353:1568-1573.
    • (1999) Lancet , vol.353 , pp. 1568-1573
    • Mottonen, T.1    Hannonen, P.2    Leirisalo-Repo, M.3    Nissila, M.4    Kautiainen, H.5    Korpela, M.6
  • 17
    • 33846976105 scopus 로고    scopus 로고
    • Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis
    • Makinen H., Kautiainen H., Hannonen P., Mottonen T., Leirisalo-Repo M., Laasonen L., et al. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007, 34:316-321.
    • (2007) J Rheumatol , vol.34 , pp. 316-321
    • Makinen, H.1    Kautiainen, H.2    Hannonen, P.3    Mottonen, T.4    Leirisalo-Repo, M.5    Laasonen, L.6
  • 18
    • 27744514865 scopus 로고    scopus 로고
    • Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial
    • Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., Allaart C.F., van Zeben D., Kerstens P.J., Hazes J.M., et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum 2005, 52:3381-3390.
    • (2005) Arthritis Rheum , vol.52 , pp. 3381-3390
    • Goekoop-Ruiterman, Y.P.1    de Vries-Bouwstra, J.K.2    Allaart, C.F.3    van Zeben, D.4    Kerstens, P.J.5    Hazes, J.M.6
  • 19
    • 67449133540 scopus 로고    scopus 로고
    • Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
    • van der Kooij S.M., Goekoop-Ruiterman Y.P., de Vries-Bouwstra J.K., Guler-Yuksel M., Zwinderman A.H., Kerstens P.J., et al. Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis. Ann Rheum Dis 2009, 68:914-921.
    • (2009) Ann Rheum Dis , vol.68 , pp. 914-921
    • van der Kooij, S.M.1    Goekoop-Ruiterman, Y.P.2    de Vries-Bouwstra, J.K.3    Guler-Yuksel, M.4    Zwinderman, A.H.5    Kerstens, P.J.6
  • 20
    • 35648991026 scopus 로고    scopus 로고
    • Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial)
    • Verstappen S.M., Jacobs J.W., van der Veen M.J., Heurkens A.H., Schenk Y., ter Borg E.J., et al. Intensive treatment with methotrexate in early rheumatoid arthritis: aiming for remission. Computer Assisted Management in Early Rheumatoid Arthritis (CAMERA, an open-label strategy trial). Ann Rheum Dis 2007, 66:1443-1449.
    • (2007) Ann Rheum Dis , vol.66 , pp. 1443-1449
    • Verstappen, S.M.1    Jacobs, J.W.2    van der Veen, M.J.3    Heurkens, A.H.4    Schenk, Y.5    ter Borg, E.J.6
  • 21
    • 23944447850 scopus 로고    scopus 로고
    • Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
    • Fransen J., Moens H.B., Speyer I., van Riel P.L. Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial. Ann Rheum Dis 2005, 64:1294-1298.
    • (2005) Ann Rheum Dis , vol.64 , pp. 1294-1298
    • Fransen, J.1    Moens, H.B.2    Speyer, I.3    van Riel, P.L.4
  • 22
    • 0028859164 scopus 로고
    • A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study
    • The HERA Study Group
    • A randomized trial of hydroxychloroquine in early rheumatoid arthritis: the HERA Study. Am J Med 1995, 98:156-168. The HERA Study Group.
    • (1995) Am J Med , vol.98 , pp. 156-168
  • 23
    • 0030751946 scopus 로고    scopus 로고
    • Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis
    • Boers M., Verhoeven A.C., Markusse H.M., van de Laar M.A., Westhovens R., van Denderen J.C., et al. Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997, 350:309-318.
    • (1997) Lancet , vol.350 , pp. 309-318
    • Boers, M.1    Verhoeven, A.C.2    Markusse, H.M.3    van de Laar, M.A.4    Westhovens, R.5    van Denderen, J.C.6
  • 24
    • 0036166382 scopus 로고    scopus 로고
    • COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention
    • Landewe R.B., Boers M., Verhoeven A.C., Westhovens R., van de Laar M.A., Markusse H.M., et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum 2002, 46:347-356.
    • (2002) Arthritis Rheum , vol.46 , pp. 347-356
    • Landewe, R.B.1    Boers, M.2    Verhoeven, A.C.3    Westhovens, R.4    van de Laar, M.A.5    Markusse, H.M.6
  • 25
    • 0036096084 scopus 로고    scopus 로고
    • Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial
    • O'Dell J.R., Leff R., Paulsen G., Haire C., Mallek J., Eckhoff P.J., et al. Treatment of rheumatoid arthritis with methotrexate and hydroxychloroquine, methotrexate and sulfasalazine, or a combination of the three medications: results of a two-year, randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002, 46:1164-1170.
    • (2002) Arthritis Rheum , vol.46 , pp. 1164-1170
    • O'Dell, J.R.1    Leff, R.2    Paulsen, G.3    Haire, C.4    Mallek, J.5    Eckhoff, P.J.6
  • 26
    • 0344286554 scopus 로고    scopus 로고
    • Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis
    • Calguneri M., Pay S., Caliskaner Z., Apras S., Kiraz S., Ertenli I., et al. Combination therapy versus monotherapy for the treatment of patients with rheumatoid arthritis. Clin Exp Rheumatol 1999, 17:699-704.
    • (1999) Clin Exp Rheumatol , vol.17 , pp. 699-704
    • Calguneri, M.1    Pay, S.2    Caliskaner, Z.3    Apras, S.4    Kiraz, S.5    Ertenli, I.6
  • 27
    • 33646365588 scopus 로고    scopus 로고
    • Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial
    • van der Heijde D., Klareskog L., Rodriguez-Valverde V., Codreanu C., Bolosiu H., Melo-Gomes J., et al. Comparison of etanercept and methotrexate, alone and combined, in the treatment of rheumatoid arthritis: two-year clinical and radiographic results from the TEMPO study, a double-blind, randomized trial. Arthritis Rheum 2006, 54:1063-1074.
    • (2006) Arthritis Rheum , vol.54 , pp. 1063-1074
    • van der Heijde, D.1    Klareskog, L.2    Rodriguez-Valverde, V.3    Codreanu, C.4    Bolosiu, H.5    Melo-Gomes, J.6
  • 28
    • 68049099274 scopus 로고    scopus 로고
    • Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naïve patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis
    • Emery P., Fleischmann R.M., Moreland L.W., Hsia E.C., Strusberg I., Durez P., et al. Golimumab, a human anti-tumor necrosis factor alpha monoclonal antibody, injected subcutaneously every four weeks in methotrexate-naïve patients with active rheumatoid arthritis: twenty-four-week results of a phase III, multicenter, randomized, double-blind, placebo-controlled study of golimumab before methotrexate as first-line therapy for early-onset rheumatoid arthritis. Arthritis Rheum 2009, 60:2272-2283.
    • (2009) Arthritis Rheum , vol.60 , pp. 2272-2283
    • Emery, P.1    Fleischmann, R.M.2    Moreland, L.W.3    Hsia, E.C.4    Strusberg, I.5    Durez, P.6
  • 29
    • 73449118587 scopus 로고    scopus 로고
    • Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study
    • Jones G., Sebba A., Gu J., Lowenstein M.B., Calvo A., Gomez-Reino J.J., et al. Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: The AMBITION study. Ann Rheum Dis 2010, 69:88-96.
    • (2010) Ann Rheum Dis , vol.69 , pp. 88-96
    • Jones, G.1    Sebba, A.2    Gu, J.3    Lowenstein, M.B.4    Calvo, A.5    Gomez-Reino, J.J.6
  • 31
    • 0036274944 scopus 로고    scopus 로고
    • Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes
    • Genovese M.C., Bathon J.M., Martin R.W., Fleischmann R.M., Tesser J.R., Schiff M.H., et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum 2002, 46:1443-1450.
    • (2002) Arthritis Rheum , vol.46 , pp. 1443-1450
    • Genovese, M.C.1    Bathon, J.M.2    Martin, R.W.3    Fleischmann, R.M.4    Tesser, J.R.5    Schiff, M.H.6
  • 32
    • 8444239359 scopus 로고    scopus 로고
    • Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial
    • St Clair E.W., van der Heijde D.M., Smolen J.S., Maini R.N., Bathon J.M., Emery P., et al. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum 2004, 50:3432-3443.
    • (2004) Arthritis Rheum , vol.50 , pp. 3432-3443
    • St Clair, E.W.1    van der Heijde, D.M.2    Smolen, J.S.3    Maini, R.N.4    Bathon, J.M.5    Emery, P.6
  • 33
    • 31044442965 scopus 로고    scopus 로고
    • The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
    • Breedveld F.C., Weisman M.H., Kavanaugh A.F., Cohen S.B., Pavelka K., van Vollenhoven R., et al. The PREMIER study: a multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment. Arthritis Rheum 2006, 54:26-37.
    • (2006) Arthritis Rheum , vol.54 , pp. 26-37
    • Breedveld, F.C.1    Weisman, M.H.2    Kavanaugh, A.F.3    Cohen, S.B.4    Pavelka, K.5    van Vollenhoven, R.6
  • 34
    • 48149100741 scopus 로고    scopus 로고
    • Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial
    • Emery P., Breedveld F.C., Hall S., Durez P., Chang D.J., Robertson D., et al. Comparison of methotrexate monotherapy with a combination of methotrexate and etanercept in active, early, moderate to severe rheumatoid arthritis (COMET): a randomised, double-blind, parallel treatment trial. Lancet 2008, 372:375-382.
    • (2008) Lancet , vol.372 , pp. 375-382
    • Emery, P.1    Breedveld, F.C.2    Hall, S.3    Durez, P.4    Chang, D.J.5    Robertson, D.6
  • 35
    • 65349176911 scopus 로고    scopus 로고
    • Clinical efficacy and safety of abatacept in methotrexate-naïve patients with early rheumatoid arthritis and poor prognostic factors
    • Westhovens R., Robles M., Ximenes A.C., Nayiager S., Wollenhaupt J., Durez P., et al. Clinical efficacy and safety of abatacept in methotrexate-naïve patients with early rheumatoid arthritis and poor prognostic factors. Ann Rheum Dis 2009, 68:1870-1877.
    • (2009) Ann Rheum Dis , vol.68 , pp. 1870-1877
    • Westhovens, R.1    Robles, M.2    Ximenes, A.C.3    Nayiager, S.4    Wollenhaupt, J.5    Durez, P.6
  • 36
    • 77958006454 scopus 로고    scopus 로고
    • Disease remission is achieved within two years in over half of methotrexate naïve patients with early erosive rheumatoid arthritis (RA) treated with abatacept plus MTX: results from the AGREE trial
    • [abstract]
    • Westhovens R., Robles M., Nayiager S., Wollenhaupt J., Durez P., Gomez-Reino J., et al. Disease remission is achieved within two years in over half of methotrexate naïve patients with early erosive rheumatoid arthritis (RA) treated with abatacept plus MTX: results from the AGREE trial. Arthritis Rheum 2009, 60:638. [abstract].
    • (2009) Arthritis Rheum , vol.60 , pp. 638
    • Westhovens, R.1    Robles, M.2    Nayiager, S.3    Wollenhaupt, J.4    Durez, P.5    Gomez-Reino, J.6
  • 37
    • 79952032325 scopus 로고    scopus 로고
    • Reduced radiographic progression in patients with early rheumatoid arthritis (RA) treated with abatacept + methotrexate compared to methotrexate alone: 24-month outcomes
    • [abstract]
    • Bathon J., Genant H., Nayiager S., Wollenhaupt J., Durez P., Gomez-Reino J., et al. Reduced radiographic progression in patients with early rheumatoid arthritis (RA) treated with abatacept + methotrexate compared to methotrexate alone: 24-month outcomes. Arthritis Rheum 2009, 60:639. [abstract].
    • (2009) Arthritis Rheum , vol.60 , pp. 639
    • Bathon, J.1    Genant, H.2    Nayiager, S.3    Wollenhaupt, J.4    Durez, P.5    Gomez-Reino, J.6
  • 38
    • 73349117220 scopus 로고    scopus 로고
    • Inhibition of joint damage and improved clinical outcomes with a combination of rituximab and methotrexate (MTX) in patients (Pts) with early active rheumatoid arthrits (RA) who are naïve to MTX: a randomised active comparator placebo controlled trial
    • [Abstract OP-0022]
    • Tak P.P., Rigby W., Rubbert A., Peterfy C., van Vollenhoven R.F., Stohl W., et al. Inhibition of joint damage and improved clinical outcomes with a combination of rituximab and methotrexate (MTX) in patients (Pts) with early active rheumatoid arthrits (RA) who are naïve to MTX: a randomised active comparator placebo controlled trial. Ann Rheum Dis 2009, 68:75. [Abstract OP-0022].
    • (2009) Ann Rheum Dis , vol.68 , pp. 75
    • Tak, P.P.1    Rigby, W.2    Rubbert, A.3    Peterfy, C.4    van Vollenhoven, R.F.5    Stohl, W.6
  • 39
    • 68049124945 scopus 로고    scopus 로고
    • Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial
    • van Vollenhoven R.F., Ernestam S., Geborek P., Petersson I.F., Coster L., Waltbrand E., et al. Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial. Lancet 2009, 374:459-466.
    • (2009) Lancet , vol.374 , pp. 459-466
    • van Vollenhoven, R.F.1    Ernestam, S.2    Geborek, P.3    Petersson, I.F.4    Coster, L.5    Waltbrand, E.6
  • 40
    • 79953066444 scopus 로고    scopus 로고
    • In early RA with insufficient response to MTX, the addition of anti-TNF results in less radiological progression over 24 months than the addition of conventional DMARDS: results from the SWEFOT trial
    • [abstract]
    • van Vollenhoven R.F., Albertsson K., Forslind K., Geborek P., Ernestam S., Petersson I.F., et al. In early RA with insufficient response to MTX, the addition of anti-TNF results in less radiological progression over 24 months than the addition of conventional DMARDS: results from the SWEFOT trial. Ann Rheum Dis 2010, 69:534. [abstract].
    • (2010) Ann Rheum Dis , vol.69 , pp. 534
    • van Vollenhoven, R.F.1    Albertsson, K.2    Forslind, K.3    Geborek, P.4    Ernestam, S.5    Petersson, I.F.6
  • 41
    • 79551555928 scopus 로고    scopus 로고
    • TEAR: Treatment of aggressive RA; a randomized, double-blind, 2-year trial comparing immediate triple DMARD versus MTX plus etanercept to step-up from initial MTX monotherapy
    • [abstract]
    • Moreland L.W., O'Dell J.R., Paulus H., Curtis J.R., Bridges S.L., Zhang X., et al. TEAR: Treatment of aggressive RA; a randomized, double-blind, 2-year trial comparing immediate triple DMARD versus MTX plus etanercept to step-up from initial MTX monotherapy. Arthritis Rheum 2009, 60:1895. [abstract].
    • (2009) Arthritis Rheum , vol.60 , pp. 1895
    • Moreland, L.W.1    O'Dell, J.R.2    Paulus, H.3    Curtis, J.R.4    Bridges, S.L.5    Zhang, X.6
  • 42
    • 33644895018 scopus 로고    scopus 로고
    • Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial
    • Smolen J.S., Van Der Heijde D.M., St Clair E.W., Emery P., Bathon J.M., Keystone E., et al. Predictors of joint damage in patients with early rheumatoid arthritis treated with high-dose methotrexate with or without concomitant infliximab: results from the ASPIRE trial. Arthritis Rheum 2006, 54:702-710.
    • (2006) Arthritis Rheum , vol.54 , pp. 702-710
    • Smolen, J.S.1    Van Der Heijde, D.M.2    St Clair, E.W.3    Emery, P.4    Bathon, J.M.5    Keystone, E.6
  • 43
    • 0141839077 scopus 로고    scopus 로고
    • Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients
    • Vittecoq O., Pouplin S., Krzanowska K., Jouen-Beades F., Menard J.F., Gayet A., et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) 2003, 42:939-946.
    • (2003) Rheumatology (Oxford) , vol.42 , pp. 939-946
    • Vittecoq, O.1    Pouplin, S.2    Krzanowska, K.3    Jouen-Beades, F.4    Menard, J.F.5    Gayet, A.6
  • 44
    • 0033869054 scopus 로고    scopus 로고
    • The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis
    • Kroot E.J., de Jong B.A., van Leeuwen M.A., Swinkels H., van den Hoogen F.H., van't Hof M., et al. The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum 2000, 43:1831-1835.
    • (2000) Arthritis Rheum , vol.43 , pp. 1831-1835
    • Kroot, E.J.1    de Jong, B.A.2    van Leeuwen, M.A.3    Swinkels, H.4    van den Hoogen, F.H.5    van't Hof, M.6
  • 45
    • 0037310556 scopus 로고    scopus 로고
    • Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage
    • Meyer O., Labarre C., Dougados M., Goupille P., Cantagrel A., Dubois A., et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003, 62:120-126.
    • (2003) Ann Rheum Dis , vol.62 , pp. 120-126
    • Meyer, O.1    Labarre, C.2    Dougados, M.3    Goupille, P.4    Cantagrel, A.5    Dubois, A.6
  • 46
    • 70349785532 scopus 로고    scopus 로고
    • A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis
    • Vastesaeger N., Xu S., Aletaha D., St Clair E.W., Smolen J.S. A pilot risk model for the prediction of rapid radiographic progression in rheumatoid arthritis. Rheumatology (Oxford) 2009, 48:1114-1121.
    • (2009) Rheumatology (Oxford) , vol.48 , pp. 1114-1121
    • Vastesaeger, N.1    Xu, S.2    Aletaha, D.3    St Clair, E.W.4    Smolen, J.S.5
  • 47
    • 35348822055 scopus 로고    scopus 로고
    • Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients
    • Aletaha D., Funovits J., Keystone E.C., Smolen J.S. Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 2007, 56:3226-3235.
    • (2007) Arthritis Rheum , vol.56 , pp. 3226-3235
    • Aletaha, D.1    Funovits, J.2    Keystone, E.C.3    Smolen, J.S.4
  • 48
  • 49
    • 0031727365 scopus 로고    scopus 로고
    • Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care
    • van der Horst-Bruinsma I.E., Speyer I., Visser H., Breedveld F.C., Hazes J.M. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br J Rheumatol 1998, 37:1084-1088.
    • (1998) Br J Rheumatol , vol.37 , pp. 1084-1088
    • van der Horst-Bruinsma, I.E.1    Speyer, I.2    Visser, H.3    Breedveld, F.C.4    Hazes, J.M.5
  • 50
  • 51
    • 0027252478 scopus 로고
    • The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease
    • van Leeuwen M.A., van Rijswijk M.H., van der Heijde D.M., Te Meerman G.J., van Riel P.L., Houtman P.M., et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol 1993, 32(Suppl 3):9-13.
    • (1993) Br J Rheumatol , vol.32 , Issue.SUPPL. 3 , pp. 9-13
    • van Leeuwen, M.A.1    van Rijswijk, M.H.2    van der Heijde, D.M.3    Te Meerman, G.J.4    van Riel, P.L.5    Houtman, P.M.6
  • 53
    • 0032957015 scopus 로고    scopus 로고
    • Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components
    • Dougados M., Combe B., Cantagrel A., Goupille P., Olive P., Schattenkirchner M., et al. Combination therapy in early rheumatoid arthritis: a randomised, controlled, double blind 52 week clinical trial of sulphasalazine and methotrexate compared with the single components. Ann Rheum Dis 1999, 58:220-225.
    • (1999) Ann Rheum Dis , vol.58 , pp. 220-225
    • Dougados, M.1    Combe, B.2    Cantagrel, A.3    Goupille, P.4    Olive, P.5    Schattenkirchner, M.6
  • 54
    • 0030696346 scopus 로고    scopus 로고
    • Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial
    • Haagsma C.J., van Riel P.L., de Jong A.J., van de Putte L.B. Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: a randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997, 36:1082-1088.
    • (1997) Br J Rheumatol , vol.36 , pp. 1082-1088
    • Haagsma, C.J.1    van Riel, P.L.2    de Jong, A.J.3    van de Putte, L.B.4
  • 55
    • 33646468228 scopus 로고    scopus 로고
    • Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study
    • Hetland M.L., Stengaard-Pedersen K., Junker P., Lottenburger T., Ellingsen T., Andersen L.S., et al. Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 2006, 54:1401-1409.
    • (2006) Arthritis Rheum , vol.54 , pp. 1401-1409
    • Hetland, M.L.1    Stengaard-Pedersen, K.2    Junker, P.3    Lottenburger, T.4    Ellingsen, T.5    Andersen, L.S.6
  • 56
    • 45149113632 scopus 로고    scopus 로고
    • Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study
    • Hetland M.L., Stengaard-Pedersen K., Junker P., Lottenburger T., Hansen I., Andersen L.S., et al. Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study. Ann Rheum Dis 2008, 67:815-822.
    • (2008) Ann Rheum Dis , vol.67 , pp. 815-822
    • Hetland, M.L.1    Stengaard-Pedersen, K.2    Junker, P.3    Lottenburger, T.4    Hansen, I.5    Andersen, L.S.6
  • 57
    • 43949125192 scopus 로고    scopus 로고
    • Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies
    • Saunders S.A., Capell H.A., Stirling A., Vallance R., Kincaid W., McMahon A.D., et al. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum 2008, 58:1310-1317.
    • (2008) Arthritis Rheum , vol.58 , pp. 1310-1317
    • Saunders, S.A.1    Capell, H.A.2    Stirling, A.3    Vallance, R.4    Kincaid, W.5    McMahon, A.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.